Gabriela Plesa

机构：California University of Pennsylvania, Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia University · ORCID：0000-0002-4279-5943

发表论文 248 篇 · 总被引 13856 次 · h-index 40

代表论文

• Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers (2026 · Molecular Therapy · 被引 2)
• Single-day nonactivated IL-18–armed CAR T cells establish a durable, stemlike state with enhanced persistence (2026 · Blood · 被引 1)
• Humanized CD19 chimeric antigen receptor (CAR) T-cell therapy for high-risk and post-CAR relapse of B-cell acute lymphoblastic leukemia (2025 · Blood · 被引 1)
• Decade-long persistence of CD19 CAR T cells in B cell lymphomas (2026 · Nature Medicine)
• HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIV (2026 · Research Square)
• Updated overall survival, safety, and neurologic function outcomes from a phase 1 trial of bivalent chimeric antigen receptor (CAR) T cell therapy in recurrent glioblastoma (GBM). (2026 · Journal of Clinical Oncology)